Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine Model

Odds FC, Schmid J, Soll DR. Epidemiology of Candida infections in AIDS. in Mycoses in AIDS patients, Springer US 1990, Ch. 5. p. 67–74.

Odds FC. Candida and candidosis. 2nd ed. London: Baillière Tindall; 1988.

Nyirjesy P. Chronic vulvovaginal candidiasis. Am Fam Physician. 2001;63:697–702.

Hurley R. Recurrent Candida infection. Baillieres Clin Obstet Gynaecol. 1981;8:209–14.

Pfaller MA, Diekema D. Epidemiology of invasive candidiasis: a persistent public health problem. J Clin Microbiol Rev. 2007;20:133–63.

Sendid B, Cotteau A, Francois N, D'Haveloose A, Standaert A, Camus D, et al. Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links. BMC Infect Dis. 2006;6:80–9.

Buchholz HW, Engelbrecht H. Uber die depotwirkung einiger antibiotica bei vermischung mit dem kunstharz palacos. Chirurg. 1970;40:511–5.

Roller S, Covill N. The antifungal properties of chitosan in laboratory media and apple juice. Int J Food Microbiol. 1999;47:67–77.

Rabea EI, Badawy MET, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules. 2003;4:1457–65.

Mazzaferro S, Bouchemal K, Skanji R, Gueutin C, Chacun H, Ponchel G. Intestinal permeation enhancement of docetaxel encapsulated into methyl-β-cyclodextrin/poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan. J Control Release. 2012;162:568–74.

Bouchemal K, Frelichowska J, Martin L, Lienvin-Le-Moal V, Le Grand R, Dereuddre-Bosquet N, et al. Note on the formulation of thermosensitive and mucoadhesive vaginal hydrogels containing the miniCD4 M48U1 as anti-HIV-1 microbicide. Int J Pharm. 2013;454:649–252.

Lee KY, Jo WH, Kwon IC, Kim YH, Jeong SY. Structural determination and interior polarity of self-aggregates prepared from deoxycholic acid-modified chitosan in water. Macromolecules. 1998;31:378–83.

Bouchemal K, Aka-Any-Grah A, Dereuddre-Bosquet N, Martin L, Lievin-Le-Moal V, Le Grand R, et al. Thermosensitive and mucoadhesive pluronic®/hydroxypropylmethylcellulose hydrogel containing the mini CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervico-vaginal mucus. Antimicrob Agents Chemother. 2015;59:2215–22.

Grocott RG. A stain for fungi in tissue sections and smears. Using Gomori’s methenamine-silver nitrate technique. Am J Clin Pathol. 1955;25:975–9.

Fromtling RA, Galgiani JN, Pfaller MA, Espinel-Ingroff A, Bartizal KF, Bartlett MS, et al. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother. 1993;37:39–45.

Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52:1.

Xu J, McCarthy SP, Gross RA, Kaplan DL. Chitosan film acylation and effects on biodegradability. Macromolecules. 1996;29:3436–40.

Jiang GB, Quan D, Liao K, Wang H. Preparation of polymeric micelles based on chitosan bearing a small amount of highly hydrophobic groups. Carbohydr Polym. 2006;66:514–20.

Wang XH, Li DP, Wang WJ, Feng QL, Cui FZ, Xu YX, et al. Crosslinked collagen/chitosan matrix for artificial livers. Biomaterials. 2003;24:3213–20.

Schreiber SB, Bozell JJ, Hayes DG, Zivanovic S. Introduction of primary antioxidant activity to chitosan for application as a multifunctional food packaging material. Food Hydrocoll. 2013;33:207–14.

Le Tien C, Lacroix M, Ispas-Szabo P, Mateescu M. A. N-acylated chitosan: hydrophobic matrices for controlled drug release. J Control Release. 2003;93:1–13.

Zong Z, Kimura Y, Takahashi M, Yamane H. Characterization of chemical and solid state structures of acylated chitosans. Polymer. 2000;41:899–906.

Bouchemal K, Ponchel G, Mazzaferro S, Campos-Requena V-H, Gueutin C, Palmieri G-F, et al. A new approach to determine loading efficiency of Leu-enkephalin in poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan. J Drug Delivery Sci Technol. 2008;18:392–7.

Zhang M, Djabourov M, Bourgaux C, Bouchemal K. Nanostructured fluids from pluronic® mixtures. Int J Pharm. 2013;454:599–610.

Pradines B, Djabourov M, Vauthier C, Loiseau PM, Ponchel G, Bouchemal K. Gelation and micellization behaviors of pluronic® F127 hydrogel containing poly(isobutylcyanoacrylate) nanoparticles specifically-designed for mucosal application. Colloids Surf B: Biointerfaces. 2015;135:669–76.

Anderson TM, Clay MC, Cioffi AG, Diaz KA, Hisao GS, Tuttle MD, et al. Amphotericin forms an extramembranous and fungicidal sterol sponge. Nat Chem Biol. 2014;10:400–6.

Lohner K. A sponge against fungal infections. Nat Chem Biol. 2014;10:411–2.

Kang CK, Yamada K, Usuki Y, Ogita A, Fujita KI, Tanaka T. Visualization analysis of the vacuole-targeting fungicidal activity of amphotericin B against the parent strain and an ergosterol-less mutant of Saccharomyces cerevisiae. Microbiology. 2013;159:939–47.

Ellis D. Amphotericin B: spectrum and resistance. J Antimicrob Chemother. 2002;49(S1):7–10.

Zhou W, Wang Y, Jian J, Song S. Self-aggregated nanoparticles based on amphiphilic poly (lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B. Int J Nanomedicine. 2012;8:3715–28.

Fukui H, Koike T, Nakagawa T, Saheki A, Sonoke S, Tomii Y, et al. Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS®), with commerical lipid-based formulations. Int J Pharm. 2003;267:101–12.

Petit B, Bouchemal K, Vauthier C, Djabourov M, Ponchel G. The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticle on mucoadhesion due to pluronic® F68 addition. Pharm Res. 2012;29:943–52.

Sajeesh S, Bouchemal K, Sharma Chandra P, Vauthier C. Surface functionalized polymethacrylate acid based hydrogel microparticles for oral drug delivery. Eur J Pharm Biopharm. 2010;74:209–18.

Noltemeyer M, Saenger W. Structural chemistry of linear α-cyclodextrin-polyiodide complexes. X-ray crystal structures of (α-cyclodextrin)2 LiI3 I2 8H2O and (α-cyclodextrin)2 Cd0.5 I5 27H2O. Models for the blue amylose-iodine complex. J Am Chem Soc. 1980;102:2710–22.

Barratt G, Bretagne S. Optimizing efficacy of amphotericin B through nanomodification. Int J Nanomedicine. 2007;2:301–13.

Adams M, Kwon GS. Spectroscopic investigation of the aggregation state of amphotericin B during loading, freeze-drying and reconstitution of polymeric micelles. Int J Pharm Pharm Sci. 2004;7:1–6.

Yoo BK, Jalil Miah MA, Lee E-S, Han K. Reduced renal toxicity of nanoparticular amphotericin B micelles prepared with partially benzylated poly-L-aspartic acid. Biol Pharm Bull. 2006;29:1700–5.

Wang Y, Zhang Q, Zhang CL, Li P. Characterisation and cooperative antimicrobial properties of chitosan/nano-ZnO composite nanofibrous membranes. Food Chem. 2012;132:419–27.

Busscher HJ, Geertsema‐Doornbusch GI, Van der Mei HC. Adhesion to silicone rubber of yeasts and bacteria isolated from voice prostheses: influence of salivary conditioning films. J Biomed Mater Res A. 1997;34:201–9.

Alaei S, Larcher C, Ebenbichler C, Prodinger WM, Janatova J, Dierich MP. Isolation and biochemical characterization of the iC3b receptor of Candida albicans. Infect Immun. 1993;61:1395–9.

Wadsworth E, Prasad SC, Calderone R. Analysis of mannoproteins from blastoconidia and hyphae of Candida albicans with a common epitope recognized by anti-complement receptor type 2 antibodies. Infect Immun. 1993;61:4675–81.

Michael LM. Significance of cell surface charge on microbial susceptibility to chitosan, M.Sc. Thesis, The University of Tennessee, Knoxville, August 2005

Tayel AA, Moussa S, Wael F, Knittel D, Opwis K, Schollmeyer E. Anticandidal action of fungal chitosan against Candida albicans. Int J Biol Macromol. 2010;47:454–7.

Vieira DB, Carmona-Ribeiro AM. Cationic lipids and surfactants as antifungal agents: mode of action. J Antimicrob Chemother. 2006;58:760–7.